Moderna Names Juan Andres As Chief Operating Officer
(RTTNews) - Moderna, Inc. (MRNA), an mRNA medicine-focused company, announced the creation of a Chief Operating Officer role and Juan Andres will return to Moderna as Chief Operating Officer, effective October 5, 2026.He will report to Stéphane Bancel, the Chief Executive Officer.
Moderna also announced that Jerh Collins, the Chief Technical Operations and Quality Officer, has decided to retire from the company following four years of service.
Juan Andres previously spent nearly six years at Moderna, joining the company in 2017 and serving as Chief Technical Operations and Quality Officer from 2018 through 2022.
He later served as President, Strategic Partnerships and Enterprise Expansion before retiring from Moderna in 2023.
Moderna and Merck jointly developed intismeran autogene. The appointment comes as Moderna is advancing intismeran autogene following Phase 3 results.
Moderna's infectious disease portfolio now includes five approved vaccines, following recent U.S. and European approvals for its seasonal flu and flu-COVID combination vaccines, respectively.
MRNA has traded between $22.28 and $208.90 over the last year. The stock is currently down 6.82% at $189.55.
For more such biotech news, visit www.rttnews.com
